(Q53811346)

English

Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). (English)

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

1 reference

based on heuristic

inferred from title

diabetic retinopathy

1 reference

based on heuristic

inferred from title

proliferative diabetic retinopathy

1 reference

based on heuristic

inferred from title

Stanislao Rizzo

1

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

author name string

Federica Genovesi-Ebert

2

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

Emanuele Di Bartolo

3

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

Andrea Vento

4

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

Sofia Miniaci

5

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

George Williams

6

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

publication date

20 February 2008

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

Graefe's Archive for Clinical and Experimental Ophthalmology

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

246

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

6

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

837-842

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

https://scigraph.springernature.com/pub.10.1007/s00417-008-0774-y

0 references

Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group

1 reference

https://api.crossref.org/works/10.1007%2FS00417-008-0774-Y

21 January 2018

Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1007%2FS00417-008-0774-Y

21 January 2018

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

1 reference

https://api.crossref.org/works/10.1007%2FS00417-008-0774-Y

21 January 2018

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1007%2FS00417-008-0774-Y

21 January 2018

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

2 references

https://api.crossref.org/works/10.1007%2FS00417-008-0774-Y

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence of diabetic retinopathy among adults in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epiretinal membrane removal in diabetic eyes: comparison of viscodissection with conventional methods of membrane peeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab for patients with metastatic renal cancer: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin) to chemotherapy improves survival in metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18286296

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00417-008-0774-Y

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/18286296

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53811346&oldid=1529455181"